Scisparc provides updates upon conclusion of 2021

Tel aviv, israel, dec. 29, 2021 /prnewswire/ -- scisparc ltd. (nasdaq: sprc), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the "company" or "scisparc"), today provides updates regarding its activities in 2021.
SPRC Ratings Summary
SPRC Quant Ranking